J&J hikes US prices for a bas­ket of drugs, in­clud­ing cer­tain top-sell­ers — Reuters

As De­mo­c­ra­t­ic mem­bers of Con­gress pro­posed leg­is­la­tion to curb soar­ing drug prices on Thurs­day, the world’s biggest drug­mak­er by rev­enue John­son & John­son $JNJ raised prices for about two dozen of its pre­scrip­tion med­i­cines, adding to the hun­dreds of price hikes al­ready ini­ti­at­ed by var­i­ous drug­mak­ers in 2019.

Most of the in­creas­es on J&J’s drugs — in­clud­ing top-sell­ers pso­ri­a­sis drug Ste­lara, can­cer drug Zyti­ga and blood thin­ner Xarel­to — were be­tween 6% and 7%, ac­cord­ing to a re­port by Reuters, cit­ing da­ta from Rx Sav­ings So­lu­tions, which helps health plans, em­ploy­ers and em­ploy­ees seek cheap­er pre­scrip­tion med­i­cines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER